Carnitine reduced erythropoietin dose required and improved cardiac function of patients on maintenance hemodialysis

Intravenous administration of 2 g carnitine in every hemodialysis (3 times/week), for 8–10 months, reduced doses of darbepoetin alfa required to maintain adequate hemoglobin levels (10–11 g/dL) into 10% of the initial doses. There was also a significant increase in plasma transferrin saturation, inc...

Full description

Bibliographic Details
Main Authors:	Yosuke Aoki, Takako Yamamoto
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2017-01-01
Series:	Saudi Journal of Kidney Diseases and Transplantation
Online Access:	http://www.sjkdt.org/article.asp?issn=1319-2442;year=2017;volume=28;issue=3;spage=477;epage=482;aulast=Aoki

id	doaj-9a214515133a48ed9686e4ada721a4cd
record_format	Article
spelling	doaj-9a214515133a48ed9686e4ada721a4cd2020-11-24T23:42:28ZengWolters Kluwer Medknow PublicationsSaudi Journal of Kidney Diseases and Transplantation1319-24422017-01-0128347748210.4103/1319-2442.206445Carnitine reduced erythropoietin dose required and improved cardiac function of patients on maintenance hemodialysisYosuke AokiTakako YamamotoIntravenous administration of 2 g carnitine in every hemodialysis (3 times/week), for 8–10 months, reduced doses of darbepoetin alfa required to maintain adequate hemoglobin levels (10–11 g/dL) into 10% of the initial doses. There was also a significant increase in plasma transferrin saturation, increase in left ventricular ejection fraction, and decrease in plasma brain natriuretic peptides.http://www.sjkdt.org/article.asp?issn=1319-2442;year=2017;volume=28;issue=3;spage=477;epage=482;aulast=Aoki
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	Yosuke Aoki Takako Yamamoto
spellingShingle	Yosuke Aoki Takako Yamamoto Carnitine reduced erythropoietin dose required and improved cardiac function of patients on maintenance hemodialysis Saudi Journal of Kidney Diseases and Transplantation
author_facet	Yosuke Aoki Takako Yamamoto
author_sort	Yosuke Aoki
title	Carnitine reduced erythropoietin dose required and improved cardiac function of patients on maintenance hemodialysis
title_short	Carnitine reduced erythropoietin dose required and improved cardiac function of patients on maintenance hemodialysis
title_full	Carnitine reduced erythropoietin dose required and improved cardiac function of patients on maintenance hemodialysis
title_fullStr	Carnitine reduced erythropoietin dose required and improved cardiac function of patients on maintenance hemodialysis
title_full_unstemmed	Carnitine reduced erythropoietin dose required and improved cardiac function of patients on maintenance hemodialysis
title_sort	carnitine reduced erythropoietin dose required and improved cardiac function of patients on maintenance hemodialysis
publisher	Wolters Kluwer Medknow Publications
series	Saudi Journal of Kidney Diseases and Transplantation
issn	1319-2442
publishDate	2017-01-01
description	Intravenous administration of 2 g carnitine in every hemodialysis (3 times/week), for 8–10 months, reduced doses of darbepoetin alfa required to maintain adequate hemoglobin levels (10–11 g/dL) into 10% of the initial doses. There was also a significant increase in plasma transferrin saturation, increase in left ventricular ejection fraction, and decrease in plasma brain natriuretic peptides.
url	http://www.sjkdt.org/article.asp?issn=1319-2442;year=2017;volume=28;issue=3;spage=477;epage=482;aulast=Aoki
work_keys_str_mv	AT yosukeaoki carnitinereducederythropoietindoserequiredandimprovedcardiacfunctionofpatientsonmaintenancehemodialysis AT takakoyamamoto carnitinereducederythropoietindoserequiredandimprovedcardiacfunctionofpatientsonmaintenancehemodialysis
_version_	1725504441641074688

Carnitine reduced erythropoietin dose required and improved cardiac function of patients on maintenance hemodialysis

Similar Items